Helus Pharma Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
10.69
+0.14 (1.33%)
At close: Oct 19, 2026, 4:00 PM EDT
10.76
+0.07 (0.68%)
After-hours: Oct 19, 2026, 4:40 PM EDT
Helus Pharma Market Cap
Helus Pharma has a market cap or net worth of $781.01 million as of October 19, 2026. It is the 11,720th most valuable company in the world and the 2,402nd biggest in the United States. Its market cap has increased by 414.02% in one year.
Market Cap
781.01M
Enterprise Value
614.65M
1-Year Change
414.02%
Global Rank
Country Rank
#2,402 United States
Category
ChartMarket Cap Chart
Since November 11, 2020, Helus Pharma's market cap has increased from $91.10M to $781.01M, an increase of 757.36%. That is a compound annual growth rate of 43.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 781.01M | 91.33% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 821.47M |
| MoonLake Immunotherapeutics | 812.77M |
| Kura Oncology | 807.76M |
| SpyGlass Pharma | 802.75M |
| Corvus Pharmaceuticals | 800.83M |
| Alumis | 792.14M |
| Ardelyx | 769.99M |
| Geron | 751.69M |